Clinical characteristics of participants with type 2 diabetes
| Features | Values |
| Number of participants | 908 |
| Gender (male/female) | 565/343 |
| Age (years) | 61 (53–67) |
| Diabetes duration (years) | 12 (6–17) |
| BMI (kg/m2) | 24.89±3.62 |
| MSG (mmol/L) | 8.99 (7.79–10.45) |
| MPSG (mmol/L) | 10.05 (8.36–11.83) |
| TOR (%) | 0.34 (0.15–0.55) |
| TIR (%) | 0.66 (0.45–0.85) |
| SDSG (mmol/L) | 2.27 (1.60–3.04) |
| CV (%) | 24.79 (18.80–31.92) |
| LAGE (mmol/L) | 9.20 (6.70–11.90) |
| M value | 36.97 (32.41–42.23) |
| MAGE (mmol/L) | 5.58 (3.99–7.60) |
| J index | 41.56 (30.06–58.45) |
| HBGI | 6.38 (3.26–11.10) |
| LI | 2.50 (1.48–3.79) |
| GRADE | 373.09±87.06 |
| ADRR | 218.11 (193.01–242.54) |
Normally distributed variables are presented as mean±SD, and non-normally distributed data are expressed as median with IQR.
ADRR, average daily risk range; BMI, body mass index; CV, coefficient of variation; GRADE, glycemic risk assessment diabetes equation; HBGI, high blood glucose index; LAGE, largest amplitude of glycemic excursions; LI, liability index; MAGE, mean amplitude of glycemic excursions; MPSG, mean postprandial sensor glucose; MSG, mean sensor glucose; SDSG, SD of the sensor glucose; TIR, percentage of values within the target range (3.9–10 mmol/L); TOR, percentage of values out of the target range (<3.9 mmol/L or >10 mmol/L).